Neurological manifestations of polyarteritis nodosa associated with the antiphospholipid syndrome - 16/02/08
Laurence VALEYRIE [1],
Nicolas BACHOT [1],
Jean-Claude ROUJEAU [1],
Jérôme AUTHIER [2],
Romain GHERARDI [2],
Hassan HOSSEINI [3]
Voir les affiliationsManifestations neurologiques de la périartérite noueuse associée à un syndrome des anticorps anti-phospholipides |
L'association entre syndrome des anticorps anti-phospholipides et vascularite est rare. Nous rapportons le cas d'un patient de 30 ans avec des manifestations neurologiques centrales et périphériques d'une périartérite noueuse et des anticorps anti-phospholipides associés. Un traitement immunosuppresseur par cyclophosphamide IV et corticoïdes oraux associé à une anticoagulation par anti-vitamine K a permis une stabilisation clinique.
Neurological manifestations of polyarteritis nodosa associated with the antiphospholipid syndrome |
The association between antiphospholipid syndrome (APS) and vasculitis is rare and continues to evoke great interest. We report a case with neurological manifestations of polyarteritis nodosa (PAN) and concurrent APS.
Electromyography and neuromuscular biopsy of the limb showed an axonal polyneuropathy following obliteration and necrosis of medium sized arteries, initially suggesting PAN. This vasculitis was confirmed on visceral selective arteriography, with the presence of numerous anevrysms.
Cerebral MRI revealed multiple cortical and subcortical signals in the fronto-parietal areas, corresponding to ischemic microvascular lesions of APS. This association was confirmed by the presence IgG anticardiolipid, the past medical history of skin necrotic lesions and central retinal obliteration.
Pulse intravenous cyclophosphamide, oral prednisolone and curative anticoagulation led to stabilization for 8 months.
Mots clés :
Système nerveux central
,
Système nerveux périphérique
,
Périartérite noueuse
,
Anticorps anti-phospholipides
Keywords: Central nervous system , Peripheric nervous system , Polyarteritis nodosa (PAN) , Antiphospholipid syndrome (APS)
Plan
© 2003 Elsevier Masson SAS. Tous droits réservés.
Vol 154 - N° 7
P. 479-482 - novembre 2003 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.